Publication | Closed Access

Eculizumab and Belatacept for De Novo Atypical Hemolytic Uremic Syndrome Associated With CFHR3-CFHR1 Deletion in a Kidney Transplant Recipient: A Case Report

UrologyTransplantationKidney TransplantKidney TransplantationRenal PathologyTransplantation MedicineHematologyChronic Kidney DiseaseMedicineKidney Transplant RecipientNephrologyCfhr3-cfhr1 DeletionCase Report